We are currently recruiting for an experienced, dynamic and visionary Senior Director of Cardiovascular & Renal Global Commercial Development to join our team. This pivotal role will serve as the commercial voice within the R&D Product Strategy Team (PST), driving early product strategy, Target Product Profiles (TPPs), Target Product Claims (TPCs), Stage-Gate Preparation, and Life Cycle Management (LCM) Planning and Execution. The successful candidate will contribute to the therapeutic area (TA) strategy and execution to maximize long-term asset value, optimize portfolio balance, and identify opportunities for inorganic growth. Responsibilities Commercial Leadership: Act as the primary commercial representative in the R&D Product Strategy Team (PST), influencing early product strategy, TPPs, TPCs, Stage-Gate Preparation, and LCM Planning and Execution. Product Strategy and Execution: Lead the development and execution of the Product Strategy to drive long-term asset value and optimize product profile. Inorganic Growth: Lead cross-functional assessments of prioritized indications, assets, technologies and MOA’s from the external environment, identifying and evaluating these opportunities for inorganic growth, including partnerships, acquisitions, and collaborations. Conduct data-driven commercial diligence and drive successful business development financial cases. Cross-Functional Collaboration: Collaborate with functional and regional partners (e.g., Market Access, Insights and Analytics, US and International) to present a unified commercial voice in PSTs, TALTs, and other teams, influencing strategy and investment decisions. Portfolio Optimization: Ensure a balanced portfolio by managing assets across various disease areas and risk profiles, leveraging both internal and external opportunities. Strategic Influence: Define and drive the asset strategy, ensuring alignment with overall business objectives and market needs. Qualifications Advanced degree in Business, Life Sciences, or a related field. 15+ years of experience in commercial development, strategy and/or analytics within the pharmaceutical or biotechnology industry, specifically in Cardiology and/or Nephrology. Proven track record of leading cross-functional teams and driving strategic initiatives. Strong analytical and strategic thinking skills, with the ability to influence and drive decision-making. Expertise in leading commercial assessments of external opportunities with prior experience in BD+L/M&A, analytics, consulting and/or commercial strategy. Excellent communication and collaboration skills, with the ability to work effectively with global teams. About CSL Vifor CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. We specialize in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives. Headquartered in St. Gallen, Switzerland, CSL Vifor also includes the joint company Vifor Fresenius Medical Care Renal Pharma (with Fresenius Medical Care). The parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people and delivers its lifesaving therapies to people in more than 100 countries. We want CSL to reflect the world around us At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more about Inclusion and Belonging at CSL. Do work that matters at CSL Vifor!

#J-18808-Ljbffr